Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its trifluoromethyl ketone group enables strong binding to enzyme active sites, enhancing biological activity. Also employed in the preparation of bioactive molecules with antimicrobial and anti-inflammatory properties. The compound's structure supports rapid derivatization, making it valuable in medicinal chemistry for structure-activity relationship (SAR) studies during drug discovery.